Intco Medical Technology Co., Ltd.: history, ownership, mission, how it works & makes money

From its founding in Zibo in 2009 to a 2017 Shenzhen listing under ticker 300677, Intco Medical Technology Co., Ltd. has grown into a manufacturing and innovation powerhouse-posting 9.52 billion CNY in revenue in 2024 (a 37.65% year-over-year jump), employing around 10,982 staff by December 2024, and reaching a market capitalization of 27.86 billion CNY by December 2025-fueling its rise to the top of China's disposable glove market, a global footprint across 150+ countries, and a diversified business model that combines 300+ patents, multiple domestic manufacturing bases, omnichannel distribution (Tmall, JD.com, Douyin, Pinduoduo, Sam's Club, Yonghui) and product lines spanning gloves, masks, rehab equipment and physiotherapy care to convert innovation and scale into sustained revenue and market leadership.

Intco Medical Technology Co., Ltd. (300677.SZ): Intro

Intco Medical Technology Co., Ltd. was founded in 2009 in Zibo, Shandong Province, China, focusing on medical consumables and durable medical equipment. The company went public in July 2017 on the Shenzhen Stock Exchange under the ticker 300677, and has since scaled manufacturing, R&D and global distribution. By December 2024 the company employed approximately 10,982 people. In 2024 Intco Medical reported revenue of 9.52 billion CNY (a 37.65% increase year-over-year). In October 2025 it was recognized by Shangpu Consulting Group as the top company in China's disposable glove market. Market capitalization reached 27.86 billion CNY by December 2025.

History

• 2009 - Company founded in Zibo, Shandong Province, focusing on medical consumables and durable medical equipment.
• 2010s - Rapid capacity expansion in production lines for disposable medical products, R&D investment in polymer processing and sterilization technologies.
• July 2017 - Listed on Shenzhen Stock Exchange (300677.SZ), enabling capital for scale-up and overseas expansion.
• 2020-2024 - Revenue and headcount growth accelerated as global demand for disposable products increased; 2024 revenue reached 9.52 billion CNY and headcount ~10,982.
• October 2025 - Ranked #1 in China's disposable glove market by Shangpu Consulting Group.

Ownership & Corporate Structure

Intco Medical is a publicly traded company (300677.SZ). Its capital structure and shareholder registry are reported in periodic filings to the Shenzhen Stock Exchange. As a listed enterprise it combines corporate shareholders, institutional investors and public float. The listing has provided access to equity capital to expand manufacturing capacity, R&D and overseas sales channels.

Mission, Vision & Core Values

• Mission: Deliver safe, high-quality medical consumables and devices to improve healthcare outcomes.
• Vision: Be a global leader in disposable medical solutions and durable medical equipment.
• Core values: Quality, safety, innovation, customer focus and sustainable growth.

Further corporate guidance and values are summarized here: Mission Statement, Vision, & Core Values (2026) of Intco Medical Technology Co., Ltd.

How It Works (Operations & Product Flow)

• Raw materials procurement: Polymer resins, non-woven fabrics, packaging and sterilization inputs sourced globally and domestically.
• Manufacturing: High-volume production lines for disposable gloves, gowns, masks, and other consumables; automated molding, forming and packaging systems.
• Quality & sterilization: In-house QC labs and sterilization processes (EO, gamma as applicable) ensuring regulatory compliance.
• Distribution: Domestic sales network plus export channels to hospitals, distributors and retail markets across regions.
• R&D & product development: Material science, process optimization and new device development to expand product mix and margins.

How It Makes Money (Business Model & Revenue Drivers)

• Product sales - core revenue from disposable medical consumables (gloves, gowns, masks) and durable equipment sales.
• Scale-driven manufacturing margins - high-capacity factories reduce per-unit costs and improve gross margins.
• Export growth - international sales to hospitals, distributors and procurement platforms expand addressable market.
• Value-added services - sterilization, custom OEM production and bundled supply agreements with institutional buyers.
• Innovation premium - higher-margin proprietary products and quality certifications enhance pricing power.

Key Financial & Operational Metrics

Intco Medical Technology Co., Ltd. (300677.SZ): History

• Founded as a medical-focused arm of the Intco group to commercialize disposable medical products and PPE.
• Listed on Shenzhen Stock Exchange under ticker 300677.SZ, enabling broader capital access and public investor participation.
• Growth driven by export markets, OEM contracts, and scale manufacturing during pandemic-related demand surges.

Ownership Structure

• Publicly traded on the Shenzhen Stock Exchange: ticker 300677.SZ.
• Insider ownership (management, founders, affiliates): ~36.04% (as of July 2025).
• Institutional investors: ~13.43% (as of July 2025), indicating professional investor confidence.
• Remaining shares: freely traded float held by retail and other public investors, providing market liquidity.
• Ownership mix supports aligned strategic decision-making between insiders and outside investors.

Mission

• Deliver safe, affordable disposable medical products to hospitals and healthcare providers globally.
• Invest in scalable manufacturing and quality systems to meet regulatory and clinical standards.
• Balance profitability with capacity to respond to public-health emergencies and chronic-care needs.

How It Works & Makes Money

• Primary revenue from manufacturing and sale of disposable medical supplies (PPE, wound care, single-use devices) to hospitals, distributors, and exporters.
• Business model blends direct sales, OEM/ODM contracts, and distribution partnerships-benefiting from scale production and cost efficiencies.
• Margins influenced by raw-material costs, production automation, certification access to regulated markets, and cycle demand (e.g., pandemic-driven spikes).

Intco Medical Technology Co., Ltd. (300677.SZ): Ownership Structure

• Mission: Enhance global health through reliable, practical medical consumables and durable medical equipment, delivered with transparency and ethical behavior.
• Core values: Integrity, diligence, professionalism, unity, achievement.
• Innovation focus: Continuous product refinement and service improvement to address clinical and market needs.
• Social responsibility: Serving 10,000+ clients worldwide with attention to quality, safety and accessibility.

• Product sales: Disposable medical consumables (wound care, isolation gowns, surgical supplies) and durable devices sold to hospitals, distributors and OEM partners.
• OEM and contract manufacturing: Production services for global medical brands and institutional customers.
• After-sales & service: Consumable replenishment, equipment maintenance and value-added service contracts.

Intco Medical Technology Co., Ltd. (300677.SZ): Mission and Values

• Manufacturing network: Multiple production bases located in Anhui, Jiangxi, Shandong, and Jiangsu provinces, enabling regional capacity balancing, proximity to suppliers, and scale economies.
• R&D and intellectual property: Over 300 authorized patents support continuous product innovation across materials, device design, and manufacturing processes.
• Multi-channel distribution: Products are sold through major e-commerce platforms (Tmall, JD.com, Douyin, Pinduoduo) and through retail and institutional channels including Sam's Club and Yonghui supermarkets, plus hospital and professional channels.
• Supply chain resilience: A vertically coordinated supply chain connects polymer/raw-material sourcing, in-house molding and processing, sterile packaging, and logistics hubs to serve domestic and export markets efficiently.
• Quality and certification: Product lines meet access requirements and certifications for major global markets (including regulatory clearances and quality-system audits), supporting export and institutional sales.
• Human capital: A dedicated workforce of approximately 10,982 employees as of December 2024 supports production, R&D, quality, and sales operations.

• Branded product sales - retail and e-commerce (consumer and professional disposables, wound care, orthopedics consumables).
• Institutional and hospital sales - bulk disposables and clinical consumables supplied to healthcare institutions.
• OEM/ODM manufacturing - contract manufacturing for international and domestic medical device brands.
• Export sales - direct exports and distributor partnerships across Asia, Europe, and other regions supported by compliance and certification.

• Scale manufacturing lowers per-unit cost and supports competitive pricing for high-volume disposables.
• R&D pipeline and patent portfolio enable product differentiation and defendable gross margins.
• Channel diversity (e‑commerce + retail + institutional + OEM) reduces concentration risk and increases customer reach.
• Centralized quality systems and certifications accelerate approval for export markets and institutional procurement.

• Product innovation is supported by the company's patent portfolio, enabling iterative improvements in materials and device designs that meet hospital and consumer needs.
• E‑commerce strategy leverages platform traffic and digital marketing (including short‑video channels) to grow direct-to-consumer sales alongside traditional B2B contracts.
• Robust supply‑chain management (sourcing, in‑house processing, logistics nodes) enables responsiveness to demand swings and export orders.

Intco Medical Technology Co., Ltd. (300677.SZ): How It Works

• Core product lines: disposable gloves, surgical & non‑surgical face masks, isolation gowns.
• Rehabilitation equipment: manual & electric wheelchairs, mobility scooters, rollators and ancillary accessories.
• Physiotherapy care: hot/cold compress systems, therapeutic electrodes, TENS units and related disposables.

• Direct product sales to hospitals, clinics and healthcare distributors (bulk contracts and recurring supply agreements).
• Retail and e‑commerce channels (own stores and marketplace partnerships) for consumer rehabilitation and physiotherapy products.
• OEM/ODM manufacturing agreements with international medical brands, providing capacity utilization and margin stability.
• After‑sales services and consumable replenishment programs that drive repeat revenue.

• High-volume automated production lines for gloves and masks reduce unit costs and support competitive pricing.
• Vertical integration across polymer processing, molding and final assembly yields margin capture on core consumables.
• Product certification (ISO, CE, other regulatory clearances) enables access to export markets and institutional tenders.
• R&D and incremental product upgrades (e.g., lightweight wheelchairs, intelligent rehab devices) increase ASPs and customer retention.

• Market capitalization: 27.86 billion CNY (as of December 2025), reflecting investor valuation of recurring consumables cash flows and growth in rehab/consumer segments.
• Channel mix: growing e‑commerce penetration complements stable institutional contracts, improving gross margin profile over time.
• Innovation focus: upgraded product lines and certifications broaden addressable markets and support premium pricing.

Intco Medical Technology Co., Ltd. (300677.SZ): How It Makes Money

• Core revenue streams: B2B sales to hospitals, distributors and institutional buyers; direct exports to international distributors; OEM/contract manufacturing for third parties.
• Geographic diversification: products sold in over 150 countries and regions, reducing concentration risk and enabling pricing arbitrage across markets.
• Customer base scale: serving more than 15,000 clients globally supports recurring order flow and cross-selling of expanded product lines.

• R&D and quality: ongoing investment in product development and ISO/medical certifications maintains premium pricing power and reduces product obsolescence.
• Scale advantages: centralized production and large export volumes enable competitive unit costs and flexible contract terms.
• Cross-selling & new products: expanding into adjacent consumables increases average revenue per client and reduces dependence on any single item class.